New drug combinations and targeted therapies may offer a brighter future for patients with acute myeloid leukemia – especially among older adults and others who may be more frail. A review in JAMA Oncology.
New drug combinations and targeted therapies may offer a brighter future for patients with acute myeloid leukemia – especially among older adults and others who may be more frail. A review in JAMA Oncology.
Designed by doctors. Powered by AI.
Owned by you.